Ascend Wellness Holdings (AAWH) Other Non-Current Liabilities (2022 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Other Non-Current Liabilities came in at $224.3 million in Q1 2026, up 29.41% year-on-year from $173.3 million in Q1 2025, and up 6.58% quarter-over-quarter from $210.5 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

Ascend Wellness Holdings' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $224.3 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 29.41% year-over-year to $224.3 million in Q1 2026; TTM through Mar 2026 was $224.3 million, a 29.41% increase from a year earlier, with the FY2025 full-year figure at $210.5 million, up 32.46% from the prior year.
  • Other Non-Current Liabilities improved to $224.3 million in Q1 2026 per AAWH's latest filing, from $210.5 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $224.3 million in Q1 2026 and bottomed at $1.8 million in Q3 2025.
  • The 5-year median for Other Non-Current Liabilities is $94.2 million (2023), against an average of $93.1 million.
  • Across the five-year window, Other Non-Current Liabilities jumped 719.98% in 2024 and tumbled 98.68% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $15.1 million in 2022, then soared by 494.29% to $89.6 million in 2023, then jumped by 77.34% to $158.9 million in 2024, then soared by 32.46% to $210.5 million in 2025, then grew by 6.58% to $224.3 million in 2026.
  • Per Business Quant, the three latest AAWH Other Non-Current Liabilities figures stand at $224.3 million (Q1 2026), $210.5 million (Q4 2025), and $1.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 224.31 Mn
Dec 31, 2025 210.46 Mn
Sep 30, 2025 1.80 Mn
Jun 30, 2025 184.46 Mn
Mar 31, 2025 173.34 Mn
Dec 31, 2024 158.89 Mn
Sep 30, 2024 136.69 Mn
Jun 30, 2024 122.47 Mn
Mar 31, 2024 98.72 Mn
Dec 31, 2023 89.60 Mn
Sep 30, 2023 16.67 Mn
Jun 30, 2023 16.07 Mn
Mar 31, 2023 15.57 Mn
Dec 31, 2022 15.08 Mn
Sep 30, 2022 14.84 Mn
Jun 30, 2022 10.00 Mn